---
schema_version: "secwatch.filing_event.v1"
accession: "0000896622-26-000090"
form_type: "8-K"
ticker: "ATR"
cik: "0000896622"
company_name: "APTARGROUP, INC."
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T01:26:31.258018+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aptar Q1 adjusted EPS $1.19 (-8% YoY); names Gael Touya CEO effective Sept 1

## Summary
- Reported sales up 11% to $982.9M; core sales flat; net income down 8% to $73M.
- Adjusted EPS $1.19 vs. $1.30; adjusted EBITDA margin 19.2% vs. 20.7%.
- Pharma core sales -1% (prescription -10% on emergency medicine destocking; injectables +20%).
- Beauty core sales +3%; Closures core flat; both segments saw margin compression.
- Q2 2026 adjusted EPS guidance $1.32-$1.40; declared $0.48 dividend payable May 27.

## SEC filing metadata
- accession: 0000896622-26-000090
- form_type: 8-K
- ticker: ATR
- cik: 0000896622
- company_name: APTARGROUP, INC.
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896622/000089662226000090/0000896622-26-000090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896622/000089662226000090/atr-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896622-26-000090
- JSON: https://secwatch.observer/filing/0000896622-26-000090.json
- Plain text: https://secwatch.observer/filing/0000896622-26-000090.txt

## Key facts
- Earnings Releases
  APTARGROUP, INC. reported the quarter ended March 31, 2026 results: revenue $982.9 million, net income $73 million, EPS $1.12. Guidance initiated.
  - Period: the quarter ended March 31, 2026
  - Revenue: $982.9 million
  - Net income: $73 million
  - EPS: $1.12
  - Guidance: initiated
  - Result: reported results
  source text: fragrance and beverage applications,” said Stephan B. Tanda, Aptar President and CEO. First Quarter Results For the quarter ended March 31, 2026, reported sales increased 11% to $982.9 million compared to $887.3 million in the prior year period. Core sales were flat compared to the prior year period. First Quarter Segment Sales Analysis (Change Over Prior Year) Pharma
  evidence_url: https://www.sec.gov/Archives/edgar/data/896622/000089662226000090/0000896622-26-000090-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.